New Delhi: Quadria Group’s healthcare venture arm, HealthQuad has has announced to invest an disclosed sum in AI-driven patient monitoring platform LifeSigns.
The fresh capital will be deployed in expanding the Chennai-based startup’s international footprint across Southeast Asia and the GCC region and strengthening its AI-led technology stack through selective integrations.
Founded in 2019, LifeSigns is a US FDA-approved continuous patient monitoring platform, which integrates medical grade wearable and cloud dashboard with a predictive AI engine to provide safety alters by monitoring, heart rate, respiration, temperature, blood pressure, and oxygen saturation.
It flags early signs of deterioration to enable timely clinical intervention and is stated to be adopted by 50 facilities across tier 2 cities.
So far the platform has monitored over 325,000 patients and generated more than 87,000 alerts.
According to a company release the platform has helped to reduced code blue incidents by 90 per cent, and lowered ICU readmissions by nearly 78 per cent.
Quadria’s $350 million HealthQuad Fund, backs new-age healthcare business models with global relevance.
“LifeSigns is building that layer to detect deterioration early and enable timely intervention which can significantly improve outcomes and reduce healthcare costs at scale. This is a globally relevant model and where the next wave of healthcare will be built,” said Rahul Agarwal, Partner, HealthQuad.
